Boston Scientific May Miss Earnings Expectations After Cyberattack

Boston Scientific has announced that it appears challenging to meet its financial guidance following a cyberattack. The company stated that the incident has negatively impacted its operations and revenues. Shares declined on this development. Analysts express uncertainty about how long the effects of the attack will last. The impact on the company's financial statements is expected to become clearer in the coming period. Investors are closely monitoring Boston Scientific's ability to manage this situation. This is not investment advice.

📊 BSX — Piyasa Yorumu

▼ down · 60%

The headline suggests that Boston Scientific may fail to meet earnings expectations following a cyberattack, which could exert negative pressure on the stock in the short term. Technical indicators present a mixed picture: the RSI stands at 49.7, indicating a neutral zone, while the MACD is negative but approaching its signal line. The price is just below the 20-day moving average (47.95) and above the 50-day average (47.72), suggesting a sideways trend. The recent 0.64% decline at the last close, combined with the impact of the news, increases the likelihood of a downward move in the near term. However, since there are no oversold signals among the indicators, any decline is expected to be limited.

RSI 14

49.7

MACD

-0.10

24h Δ

-0.64%

Canlı Grafikler